Want to see AU:M7T full AI Analyst Report?
Mach7 Technologies (M7T) Share Price & Analysis
M7T Stock Chart & Stats
- Day’s Range
- AUD 0.25 - AUD 0.26
- 52-Week Range
- AUD 0.21 - AUD 0.69
- Previous Close
- AUD 0.26
- Volume
- N/A
- Average Volume (3M)
- 53.82K
- Market Cap
- AUD 61.10M
- Enterprise Value
- AUD 48.31M
- Total Cash (Recent Filing)
- AUD 19.92M
- Total Debt (Recent Filing)
- AUD 80.39K
- Price to Earnings (P/E)
- ―
- Beta
- 1.20
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- -0.01
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue Base
The high recurring-revenue mix gives Mach7 greater visibility than a predominantly project-based model and supports ongoing customer relationships. A substantial contracted base can improve planning, reinforce retention economics, and provide a foundation for future growth as new modules and sites are adopted.
High Gross Margin And Cost Discipline
A 93% gross margin indicates that the software model can retain substantial value after direct costs, while the 16% operating-expense reduction establishes a leaner cost base. If revenue stabilizes, this combination creates meaningful potential for operating leverage and narrower losses.
Low-Leverage Balance Sheet
Cash of $19.9 million and no debt provide financial flexibility while Mach7 works to restore growth and profitability. The absence of refinancing obligations lowers balance-sheet pressure and preserves capacity to fund product development, implementations, or other targeted strategic investments.
Bears Say
Revenue Decline And Ongoing Losses
Falling revenue combined with a large net loss shows that Mach7 has not yet converted its software platform and high gross margin into sustainable earnings. Continued losses can restrict reinvestment and make successful execution of the growth plan essential to improving financial resilience.
Customer Losses Pressuring Recurring Revenue
The loss of sizable customers has directly weakened recurring revenue and contracted annualized revenue, demonstrating that the installed base is not fully insulated from churn or project disruption. Rebuilding those relationships through new logos and module adoption is necessary before recurring growth becomes durable.
Negative And Volatile Cash Generation
Returning to negative operating and free cash flow raises execution risk even though the company currently holds cash and no debt. The history of large swings suggests cash conversion is not yet dependable, so persistent underperformance could gradually reduce the funding runway available for growth initiatives.
M7T FAQ
What was Mach7 Technologies’s price range in the past 12 months?
What is Mach7 Technologies’s market cap?
When is Mach7 Technologies’s upcoming earnings report date?
How were Mach7 Technologies’s earnings last quarter?
Is Mach7 Technologies overvalued?
Does Mach7 Technologies pay dividends?
What is Mach7 Technologies’s EPS estimate?
How many shares outstanding does Mach7 Technologies have?
What happened to Mach7 Technologies’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Mach7 Technologies?
What is the TipRanks Smart Score and how is it calculated?
Mach7 Technologies Stock Smart Score
Company Description
Mach7 Technologies
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists’ workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Teri Thomas
- Employees
- 167
- Website
- www.mach7t.com
- Address
- 385 Bourke Street, Melbourne, VIC, 3000, AU
Mach7 Technologies (M7T) Earnings & Revenues
M7T Company Deck
M7T Earnings Call
Earnings Call SentimentPositive
The call presented a cautious but constructive tone: FY'26 was framed as a deliberate reset that materially improved the business foundation—higher-quality recurring revenue mix, a 93% gross margin, reduced operating costs, a stronger leadership team, and clear second-half commercial momentum (ARR run rate +7.6% constant currency; H2 revenue +15% vs H1). However, meaningful near-term challenges remain including a 17% reported revenue decline, several sizable customer losses (notably VHA and Trinity Health), an $8.9M net loss, and FX-driven reporting headwinds. Management emphasized stabilization and a roadmap (Flamingo modules, Epic integrations, focused partnerships) to prove growth in FY'27. Overall, positives around margin, cash/no debt, cost discipline and H2 recovery modestly outweigh the lowlights, supporting cautious optimism.
View all AU:M7T earnings summariesM7T Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 6 | 7 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 6 | 0 | 6 |










